Tumor News and Research

RSS

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

9 Sep 2023

Researchers uncover evidence supporting shorter-course proton therapy for breast cancer patients

In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients.

8 Sep 2023

Capture and release of tumor cells using a bioelectronic device

In the book entitled Microfluidic Systems for Cancer Diagnosis, the UPV/EHU’s Microfluidics Cluster group describes the process for building a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way while monitoring the processes using conventional electrical measurements.

8 Sep 2023

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

Vibrant green leaves sprout from tall fragrant plants sitting neatly in two rows of terracotta pots in Valerie Sponsel's UTSA biology laboratory.

8 Sep 2023

Promising new cervical cancer test fills in the gap missed by Pap tests

Researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for adenocarcinoma in-situ (AIS) and cervical adenocarcinoma (ADC) screening.

8 Sep 2023

Study unveils a potential solution to combat age-related immune system decline

As we age, our bodies face numerous challenges, including a decline in immune system function and an increased vulnerability to various health issues.

7 Sep 2023

New test could detect brain tumors using cerebrospinal fluid

Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors by measuring abnormal genetic material shed by tumors and circulating in cerebrospinal fluid (CSF).

7 Sep 2023

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Researchers performed a multi-omics evaluation of HSPCs obtained from individuals with myeloproliferative neoplasms transforming to TP53-related secondary forms of acute myeloid leukemia.

7 Sep 2023

Novel method using DNA nanoballs could revolutionize pathogen detection

Researchers at Karolinska Institute have developed a novel method using DNA Nanoballs to detect pathogens, aiming to simplify nucleic acid testing and revolutionize pathogen detection.

7 Sep 2023

New device can help test treatments in patients with gliomas

The shape and size of a grain of rice, the new device can conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

7 Sep 2023

Eating for health: how dietary interventions impact pre-diabetic oral and gut microbiome, metabolites and cytokines

Researchers evaluated the impact of two diets on the intestinal and oral microbiota, cytokines, and metabolites of 200 pre-diabetic individuals.

7 Sep 2023

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.

6 Sep 2023

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.

5 Sep 2023

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

A multidisciplinary team of investigators from the UCLA Jonsson Comprehensive Cancer Center was awarded a $2.5 million Translational Team Science Award from the Department of Defense to develop a tailored treatment for glioblastoma, a deadly brain tumor with limited treatment options.

5 Sep 2023

Could medicinal plants be the key to reversing cognitive decline?

Researchers explore available evidence that medicinal plants may help improve cognitive function by reducing brain inflammation.

5 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

Silencing two genes can make cancer cells receptive to chemotherapy

Scientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it.

4 Sep 2023

New breakthroughs by NPL scientists could transform cancer treatment

New breakthroughs by scientists at the National Physical Laboratory (NPL) are set to transform cancer treatment in the UK and worldwide.

4 Sep 2023

Study finds ways to improve medication adherence in breast cancer survivors

For roughly 80% of breast cancer survivors, treatment doesn't end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take medication to block sex hormones, which can fuel tumor growth and spark recurrence.

1 Sep 2023

Scientists reclassify 200 rare immune system disorders using network-based approach

Scientists at CeMM, Max Perutz Labs, and St. Anna Children's Cancer Research Institute in Vienna have achieved a significant advancement in the research of rare immune system disorders.

1 Sep 2023

Tumor News and Research

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Researchers uncover evidence supporting shorter-course proton therapy for breast cancer patients

Capture and release of tumor cells using a bioelectronic device

UTSA researchers study the mechanism of action of Sweet Annie's medicinal compounds

Promising new cervical cancer test fills in the gap missed by Pap tests

Study unveils a potential solution to combat age-related immune system decline

New test could detect brain tumors using cerebrospinal fluid

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Novel method using DNA nanoballs could revolutionize pathogen detection

New device can help test treatments in patients with gliomas

Eating for health: how dietary interventions impact pre-diabetic oral and gut microbiome, metabolites and cytokines

MD Anderson and Panacea create Manaolana Oncology to develop novel portfolio of monoclonal antibodies

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Researchers receive $2.5 million award to develop a tailored treatment for glioblastoma

Could medicinal plants be the key to reversing cognitive decline?

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

Silencing two genes can make cancer cells receptive to chemotherapy

New breakthroughs by NPL scientists could transform cancer treatment

Study finds ways to improve medication adherence in breast cancer survivors

Scientists reclassify 200 rare immune system disorders using network-based approach

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News